Author Correction: An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in

Huiping Shuai1, Jingxin Qiao2, Chaemin Yoon1

  • 1State Key Laboratory of Emerging Infectious Diseases, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, and Pandemics Research Alliance Unit at The University of Hong Kong, Hong Kong Special Administrative Region, China.

Nature Communications
|December 15, 2025
PubMed
Abstract

No abstract available in PubMed .